Location History:
- Hanover, NH (US) (2018)
- Norwich, VT (US) (2017 - 2024)
- Austin, TX (US) (2020 - 2024)
Company Filing History:
15 out of 3,539 
5 out of 664 
2 out of 1,187 
Years Active: 2017-2024
Title: The Innovative Contributions of Jason Scott McLellan
Introduction
Jason Scott McLellan is a prominent inventor based in Austin, Texas, with an impressive portfolio consisting of 18 patents. His work primarily focuses on innovations in the field of virology, particularly related to respiratory viruses. McLellan's groundbreaking research has played a significant role in advancing vaccine development and diagnostic methods.
Latest Patents
Among his latest patents, two stand out for their potential impact on public health. The first is the "Prefusion-stabilized hMPV F proteins," which details engineered human metapneumovirus (hMPV) F proteins with enhanced conformational stability and antigenicity. This innovation has important applications in diagnostics, screening platforms, and vaccine compositions.
The second patent, "Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 F protein and uses thereof," introduces recombinant paramyxoviruses with a viral genome encoding a heterologous gene. This recombinant parainfluenza virus, which includes a respiratory syncytial virus F ectodomain, may be utilized in developing effective vaccine formulations against parainfluenza virus and respiratory syncytial virus.
Career Highlights
McLellan has made significant contributions to the scientific community through his innovative research. He has worked with esteemed organizations such as the United States Department of Health and Human Services and Dartmouth College. His efforts in virology have not only advanced the scientific understanding of respiratory viruses but have also paved the way for novel therapeutic strategies.
Collaborations
Throughout his career, Jason has collaborated with talented individuals in the field. Notable coworkers include Barney S. Graham and Michael Gordon Joyce. Their teamwork has resulted in numerous advancements in vaccine research and development, showcasing the collaborative spirit of scientific inquiry.
Conclusion
Jason Scott McLellan's dedication to innovation in virology has positioned him as a leading inventor. With 18 patents highlighting his expertise, his developments in engineered proteins and recombinant viruses stand to significantly impact public health. As he continues his work, the scientific community eagerly anticipates the advancements that will stem from his innovative contributions.